InsiderTrades

Form 4 for OGN Organon & Co.

Accepted 2022-05-05 00:00:00 ET · period of report 2022-05-03 · accession 0001104659-22-056629 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-05-05 2022-05-03+ OGN Morrissey Joseph T. Jr. Head of Manufacturing M - OptEx — +6,406 11.3K +130% —
DM 2022-05-05 2022-05-03+ OGN Morrissey Joseph T. Jr. Head of Manufacturing F - Tax $32.28 -1,825 7,741 -19% -$58.9K
DM 2022-05-05 2022-05-03+ OGN Morrissey Joseph T. Jr. Head of Manufacturing M - OptEx $0.00 -6,406 3,599 -64% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-03 M A 2,807 — 8,541 D — — (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
2 Common Common Stock 2022-05-04 F D 1,025 $32.44 10,315 D — —
3 Common Common Stock 2022-05-04 M A 3,599 — 11,340 D — — (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
4 Common Common Stock 2022-05-03 F D 800 $32.08 7,741 D — —
5 Derivative Restricted Stock Units 2022-05-03 M D 2,807 $0.00 2,807 D — · 2022-05-03 to 2022-05-03 2,807 Common Stock (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
6 Derivative Restricted Stock Units 2022-05-04 M D 3,599 $0.00 3,599 D — · 2022-05-04 to 2024-05-04 3,599 Common Stock (F2) The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. (F3) On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024.